Orchid Pharma was taken over by Dhanuka Laboratories after the proceedings of NCLT. Furthermore, Dhanuka Laboratories owns about 98.04% of the entire stake of the company.
This is a perfect instance of disparity of demand and supply. When there was a demand of 135,000 shares (buy orders), only a little to 83 shares were traded in the market (as of November 2020). This created a false image that the stock is highly demanded. When in reality, the supply was just less.
No comments:
Post a Comment